Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioventus (BVS) Other Non Operating Income (2020 - 2026)

Bioventus filings provide 6 years of Other Non Operating Income readings, the most recent being -$1.1 million for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 179.21% to -$1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.5 million, a N/A change, with the full-year FY2025 number at -$1.5 million, changed N/A from a year prior.
  • Other Non Operating Income hit -$1.1 million in Q4 2025 for Bioventus, down from -$79000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.6 million in Q2 2023 to a low of -$9.4 million in Q4 2022.
  • Median Other Non Operating Income over the past 5 years was -$411500.0 (2021), compared with a mean of -$624300.0.
  • Biggest five-year swings in Other Non Operating Income: soared 1325.23% in 2021 and later plummeted 1133.33% in 2025.
  • Bioventus' Other Non Operating Income stood at $1.4 million in 2021, then tumbled by 792.21% to -$9.4 million in 2022, then surged by 107.53% to $709000.0 in 2023, then crashed by 156.98% to -$404000.0 in 2024, then plummeted by 179.21% to -$1.1 million in 2025.
  • The last three reported values for Other Non Operating Income were -$1.1 million (Q4 2025), -$79000.0 (Q3 2025), and -$561000.0 (Q2 2025) per Business Quant data.